Prevalence of Adverse Drug Reactions in CAD STEMI Patients Treated in the Cardiac Intensive Care Unit at the Public Hospital in Bandung, Indonesia
- PMID: 27110507
- PMCID: PMC4839262
- DOI: 10.3797/scipharm.ISP.2015.08
Prevalence of Adverse Drug Reactions in CAD STEMI Patients Treated in the Cardiac Intensive Care Unit at the Public Hospital in Bandung, Indonesia
Abstract
Adverse drug reactions (ADRs) are associated with morbidity, mortality, and can contribute to increased healthcare costs. This study was conducted to identify the occurence, types, and management of ADRs, as well as analyze the causal relationship, severity, and preventability of ADRs. The study was observational analysis with concurrent data collection from patients with Coronary Artery Disease-ST segment Elevation Myocardial Infarction (CAD-STEMI) treated in the Cardiac Intensive Care Unit (CICU) at a hospital in Bandung Indonesia, during the period of December 2013 to March 2014. The occurence of identified ADRs was assessed using the probability scale of Naranjo, while the severity by the scale of Hartwig and their preventability was evaluated using the scale of Schumock-Thornton. 49 ADRs were identified in 29 patients. Organ systems most affected by the ADRs were the cardiovascular and body electrolyte, each accounting for 20.41%. The hematology and gastrointestinal systems each contributed 18.37% to ADR occurrences. The causal relationship was mostly classified as "probable," accounting for 69.39%. With regard to severity, most ADRs were classified as "moderate" at level 3, contributing to 53.06% of the occurence. In terms of preventability, most of the ADRs fell into the "non-preventable" category (79.59%). The most widely applied ADRs management was administration of an antidote or other treatments (40.82%). Further analysis revealed that the average number of drug types and duration of hospitalization significantly affected the presence of ADRs. Taken together, most patients with CAD STEMI treated in the CICU of the studied hospital experienced non-preventable ADRs and were treated with antidote or other treatments.
Keywords: ADRs; CAD STEMI; Hartwig; Naranjo; Schumock-Thornton scales.
Figures





References
-
- World Health Organization. Cardiovascular Diseases, Fact Sheet No 317. 2013. [accessed on 9 May, 2014]. http://www.who.int/mediacentre/factsheets/fs317/en/index.html .
-
- World Health Organization. The Global Burden of Disease: 2004 Update. Geneva: WHO; 2004. - PubMed
-
- Beltrame JF, Dreyer R, Tavella R. Gaze D. Epidemiology of coronary artery disease. Coronary artery disease - current concepts in epidemiology, pathophysiology, diagnostics and treatment. 2012. pp. 1–30. http://dx.doi.org/10.5772/29030 .
-
- Delima Mihardja L, Siswoyo H. Prevalensi dan Faktor Determinan Penyakit Jantung di Indonesia. Buletin Penelitian Kesehatan. 2009;37:142–159.
-
- Kane-Gill SL, Jacobi J, Rothschild JM. Adverse Drug Events In Intensive Care Units: Risk Factors, Impact, and The Role of Team Care. Crit Care Med. 2010;38(Suppl):S83–S89. http://dx.doi.org/10.1097/CCM.0b013e3181dd8364 . - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous